Heron Therapeutics Inc
NASDAQ:HRTX 3:59:53 PM EDT
| Market Cap (Intraday) | 324.87M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.43 |
| 50-Day MA | $4.87 |
| 200-Day MA | $8.47 |
Heron Therapeutics Inc Stock, NASDAQ:HRTX
4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 302
Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.